Will Express Scripts Earnings Keep Getting Healthier?
The pharmacy-benefits manager reports Monday, and Express Scripts earnings look poised to keep climbing.
3 Reasons Catamaran Is a Buy
Catamaran shareholders have enjoyed a 2,742% gain in the past five years. Even after the run-up, here are three reasons the stock is still a buy today.
Why Catamaran Is Poised to Bounce Back
Market-trouncing returns could be written in this 5-Star.